This study is one of the first to stratify injury severity based on the type of surgical treatment required.
Neurologist to lead first-ever study of kids with Down syndrome to assess their likelihood of developing Alzheimer’s disease in adulthood
The study will examine biochemical markers in the blood of children with Down syndrome for a likelihood of them developing Alzheimer’s disease in adulthood.
Dr. Anthony Chang, a bold visionary for artificial intelligence in medicine, has put CHOC on the international stage
CHOC’s chief intelligence and innovation officer, Dr. Chang, works to develop uses of artificial intelligence (AI) to improve healthcare.
Neurologist awarded patent for novel technology to treat victims of brain injury and stroke
The patent for light-emitting nanoparticles will significantly advance CHOC’s research to develop non-invasive treatments for brain injuries.
Virtual psychosocial support improves adolescent and young adult oncology outcomes during pandemic
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.
CHOC joins select group of U.S. healthcare systems designated as a Rare Disease Center of Excellence
CHOC and UCI Health’s new designation is expected to attract more resources and recognition to help find novel cures for rare disorders.
